XLXiang Li

Xiang Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiang Li has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma

    by Kang Sun, Xiaozhen Zhang, Jiatao Shi, Jinyan Huang, Sicheng Wang, Xiang Li, Haixiang Lin, Danyang Zhao, Mao Ye, Sirui Zhang, et al.

    Metabolic reprogramming shapes the tumor microenvironment (TME) and may lead to immunotherapy resistance in pancreatic ductal adenocarcinoma (PDAC). Elucidating the impact of pancreatic cancer cell metabolism in the TME is essential to therapeutic interventions. “Immune cold” PDAC is characterized by elevated lactate levels resulting from tumor cell metabolism, abundance of protumor macrophages, and reduced cytotoxic T cells in the TME. Analysis of fluorine-18 fluorodeoxyglucose ( 18 F-FDG) uptake in patients showed that increased global protein lactylation in PDAC correlates with worse clinical outcomes in immunotherapy. Inhibition of lactate production in pancreatic tumors via glycolysis or mutant-KRAS inhibition reshaped the TME, thereby increasing their sensitivity to immune checkpoint blockade (ICB) therapy. In pancreatic tumor cells, lactate induces K63 lactylation of endosulfine α (ENSA-K63la), a crucial step that triggers STAT3/CCL2 signaling. Consequently, elevated CCL2 secreted by tumor cells facilitates tumor-associated macrophage (TAM) recruitment to the TME. High levels of lactate also drive transcriptional reprogramming in TAMs via ENSA-STAT3 signaling, promoting an immunosuppressive environment. Targeting ENSA-K63la or CCL2 enhances the efficacy of ICB therapy in murine and humanized pancreatic tumor models. In conclusion, elevated lactylation reshapes the TME and promotes immunotherapy resistance in PDAC. A therapeutic approach targeting ENSA-K63la or CCL2 has shown promise in sensitizing pancreatic cancer immunotherapy.


  • Prediction of New-Onset Diabetes After Pancreatectomy With Subspace Clustering Based Multi-View Feature Selection

    by Peijun Hu, Xiang Li, Na Lu, Kaiqi Dong, Xueli Bai, Tingbo Liang, Jingsong Li

    The pancreas plays an important role in glucose metabolism, and developing diabetes or long-term glucose metabolism disturbance may be a prevalent sequela after pancreatectomy. Nevertheless, relative factors of new-onset diabetes after pancreatectomy stay unclear. Radiomics analysis is potential to identify image markers for disease prediction or prognosis. Meanwhile, combination of imaging and electronic medical record (EMR) showed superior performance than imaging or EMR alone in previous studies. One critical step is to identity predictors from high-dimensional features, and it is even more challenging to select and fuse imaging and EMR features. In this work, we develop a radiomics pipeline to assess postoperative new-onset diabetes risk of patients undergoing distal pancreatectomy. Specifically, we extract multiscale image features with 3D wavelet transformation, and include patients' characteristics, body composition and pancreas volume information as clinical features. Then, we propose a multi-view subspace clustering guided feature selection method (MSCUFS) for the selection and fusion of image and clinical features. Finally, a prediction model is constructed with classical machine learning classifier. Experimental results on an established distal pancreatectomy cohort showed that the SVM model with combined imaging and EMR features demonstrated good discrimination, with an AUC value of 0.824, which improved the model with image features alone by 0.037 AUC. Compared with state-of-the-art feature selection methods, the proposed MSCUFS has superior performance in fusing image and clinical features.